Simple malaria test in early pregnancy could save newborns

NCT ID NCT05757167

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether screening pregnant women for malaria with a highly sensitive rapid test during the first trimester, followed by treatment if positive, can improve newborn health. Over 2,000 women in malaria-prone areas will be compared to those receiving usual care. The goal is to reduce complications like low birth weight, preterm birth, and stillbirth.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
High-sensitivity malaria rapid diagnostic test and artemether-lumefantrine
What this could lead to
If successful, this could show that early detection and treatment of malaria in pregnancy reduces serious complications like low birth weight and stillbirth.
What could go wrong
This is a single study in one region, and results may not apply everywhere. The test may not catch all infections, and the treatment has side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GESTATIONAL AGE AND WEIGHT CONDITIONS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Kinshasa School of Public Health

    Kinshasa, Democratic Republic of the Congo

  • Moi University

    Eldoret, Kenya

More trials for these conditions

Other studies related to the condition(s) this trial covers.